3M™ Kerracel™ Gelling Fiber Dressing

Products
  • Conformable1
  • Can be used under compression2*
  • Cuttable1
  • Vertical absorption2*
 More...
View all details
Pack Quantity
Pack_Quantity
Overall Width (Imperial)
Overall_Width_Imperial
Overall Length (Imperial)
Overall_Length_Imperial
Overall Width (Metric)
Overall_Width_Metric
Overall Length (Metric)
Overall_Length_Metric
Products Available
Available options:
 Pack Quantity, Overall Width (Imperial), Overall Length (Imperial), Overall Width (Metric) and Overall Length (Metric)
All Options
Close
Specifications
Attribute Name
Value
HCPCS Code
A6196, A6197, A6199
Overall Length (Imperial)
18 in, 2 in, 5 in, 6 in
Overall Length (Metric)
12.5 cm, 15 cm, 45 cm, 5 cm
Overall Width (Imperial)
1 in, 2 in, 4 in, 6 in
Overall Width (Metric)
10 cm, 15 cm, 2.5 cm, 5 cm
Pack Quantity
10 ea/bx, 10/box, 5 ea/bx
Product Details
  • Conformable1
  • Can be used under compression2*
  • Cuttable1
  • Vertical absorption2*
  • Up to 7 days wear time
  • Up to 7 days wear time

3M™ Kerracel™ Gelling Fibre Dressing is a primary wound contact dressing with a high absorption capacity2* for the management of moderately to highly exuding, acute and chronic, deep or shallow wounds.

Made from 100% carboxymethylcellulose (CMC) fibres, Kerracel Dressing absorbs and retains high levels of exudate2* forming a gel2* which conforms to the wound bed and supports a moist wound healing environment. As fluid is absorbed vertically and locked away2, peri-wound skin is protected helping to avoid maceration4. The unstitched design aids micro-contouring to the wound bed3*, minimising dead space where bacteria can proliferate*. Conformability aids ease of application1, whilst its ability to retain integrity when wet2* helps to facilitate integral removal. 1 Cook J. Evaluation of cuttability, conformability, thickness and bi-directionality of KERRACEL™ Dressing. R&D Trial Report CHC R1039. Knutsford, UK. Crawford Healthcare. 2020. 2 Erbogasto D. Physical testing of KERRACEL™ Dressing and market competitors. R&D Trial Report CHC R1004. Knutsford, UK. Crawford Healthcare. 2020. 3 Lovett J, Stephenson C. An assessment of the intimate wound contact properties of KERRACEL™ Dressings. CHL-032. University of Manchester. UK. 2014. 4 Jones N, Ivins N, Ebdon V, Hagelstein S, Harding K. A case series evaluating the use of a gelling fibre dressing for moderate to highly exuding wounds. Wounds UK 13: 3: 72-78. *As demonstrated in vitro

Suggested Applications

  • Can be used on moderately to highly exuding chronic or acute wounds such as: leg ulcers, pressure ulcers, diabetic foot ulcers, surgical wounds, donor sites, cavity wounds, trauma wounds, superficial and partial thickness burns, control minor bleeding in superficial wounds